Fan Pan
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, Cell BiologyGoogle:
"Fan Pan"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Riaz F, Wei P, Pan F. (2023) PPARs at the crossroads of T cell differentiation and type 1 diabetes. Frontiers in Immunology. 14: 1292238 |
| Wei P, Kou W, Riaz F, et al. (2023) Combination therapy of HIFα inhibitors and Treg depletion strengthen the anti-tumor immunity in mice. European Journal of Immunology. e2250182 |
| Wei P, Kou W, Fu J, et al. (2023) Pparα knockout in mice increases the Th17 development by facilitating the IKKα/RORγt and IKKα/Foxp3 complexes. Communications Biology. 6: 721 |
| Dong Y, Yang C, Pan F. (2021) Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications. Frontiers in Immunology. 12: 626172 |
| Dong Y, Pan F. (2021) Ubiquitin-Dependent Regulation of Treg Function and Plasticity. Advances in Experimental Medicine and Biology. 1278: 63-80 |
| Samanta D, Huang TY, Shah R, et al. (2020) BIRC2 Expression Impairs Anti-Cancer Immunity and Immunotherapy Efficacy. Cell Reports. 32: 108073 |
| Yang J, Wei P, Barbi J, et al. (2020) The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation. Embo Reports. e50308 |
| Hurwitz LM, Kulac I, Gumuskaya B, et al. (2020) Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prevention Research (Philadelphia, Pa.) |
| Morianos I, Trochoutsou AI, Papadopoulou G, et al. (2020) Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways. Proceedings of the National Academy of Sciences of the United States of America |
| Lebid A, Chung L, Pardoll DM, et al. (2020) YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response. Frontiers in Immunology. 11: 580 |